← All companies
Mirum Pharmaceuticals, Inc.
MIRM - CIK 0001759425
Market cap$5.73 B
Rank#1294
SEC filings612
The table below shows Mirum Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $324.91M | $282.02M | $228.12M | $211.82M | $222.97M | $233.25M |
| Short-term investments | $61.35M | $93.53M | $76.43M | $65.85M | $61.48M | $45.13M |
| Receivables | $133.11M | $107.13M | $106.84M | $95.85M | $68.53M | $60.43M |
| Inventory | $25.52M | $24.02M | $22.94M | $22.42M | $21.59M | $20.44M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.